Are you a journalist?

Learn to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

See all
  • Post date
    12/20/2024
    ALK – Financial calendar for the 2025 financial year
    Read more
  • Post date
    12/18/2024
    Positive results advance peanut tablet to phase II development
    Read more
  • Post date
    12/12/2024
    ACARIZAX® approved in Europe for treatment of young children
    Read more
  • Post date
    11/27/2024
    ALK’s pivotal phase 3 trial in children published in reputable scientific journal
    Read more
  • Post date
    11/14/2024
    Nine-month interim report (Q3) 2024 (unaudited)
    Read more
  • Post date
    11/09/2024
    ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
    Read more
  • Post date
    11/07/2024
    Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024
    Read more
  • Post date
    08/27/2024
    Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
    Read more
  • Post date
    08/22/2024
    Six-month interim report (Q2) 2024
    Read more

Media Relations

Per Plotnikof
Vice President,
Corporate Communications,
Investor Relations and Strategic Planning
Phone: +45 22612525
Email: PPIDK@alk.net

Jeppe Ilkjær
Media Relations Manager
Corporate Communications
Phone: +45 30502014
Email: Jeppe.Ilkjaer@alk.net

About ALK
Read more about the profile of ALK, the market leader in allergy immunotherapy
Key financial figures
Read more about ALK’s latest financial results
Journalists are always welcome to contact ALK’s Media Relations team.

Images

Find a wide selection of images available for download for the press
Steen Riisgaard, CEO
Download image
Production facilities, Hørsholm
Download image
alk_produktion6_0
Production facilities, Hørsholm
Download image
alk_produktion3_1
Production facilities, Hørsholm
Download image
alk_produktion5
Production facilities, Hørsholm
Download image
Family_website_0
ALK HQ, Hørsholm
Download image
Last updated: 2016.11.14